Photothermal-
radiotherapy (PT-RT) is an effective strategy for relieving
hypoxia-related
radiotherapy resistance and inducing
tumor-specific cell apoptosis/
necrosis. Nevertheless, limited tissue penetration of near-infrared (NIR)
laser and the serious side effects of high-dose radiation severely hinder its applications for deep
tumors. An interventional photothermal-
brachytherapy (IPT-BT) technology is proposed here for the internal site-specific treatment of deep
tumors. This technology utilizes a kind of biodegradable honeycomb-like
gold nanoparticles (HGNs) acting as both internal photothermal agents and radiosensitizers. A high
tumor inhibition rate of 96.6% is achieved in SW1990 orthotopic pancreatic
tumor-bearing mice by HGNs-mediated IPT-BT synergistic
therapy. Interestingly, this approach effectively causes
double-stranded DNA damage and improves the
oxygen supply and the penetration of nanoparticles inside the
tumor. Therefore, it is believed that this strategy may open up a new avenue for PT-RT synergistic
therapy of deep malignant
tumors and has a significant impact on the future clinical translation.